CLINICS 2011;66(10):1817-1823 Biol Phys. 2010 12(ahead of print). Int J Radiat Oncol Biol Phys. 2011;80:1430-5. Epub 2010 Aug 12, doi: 10.1016/j.ijrobp.2010.04.061. 53. Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK, Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg. 2002;28:113- 7;discussion 7, doi: 10.1046/j.1524-4725.2002.02901.x 54. Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg. 1997;174:688-93, doi: 10.1016/S0002-9610(97)00193-1. 55. Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006 1;64(1):114- 9, doi: 10.1016/j.ijrobp.2005.04.042. 56. Garneski KM, Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol. 2007;57:166-9, doi: 10.1016/j.jaad.2007.03.011. 57. Pacella J, Ashby M, Ainslie J, Minty C. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (Merkel cell or trabecular carcinoma): experience at the Peter MacCallum Cancer Institute (Melbourne, Australia). Int J Radiat Oncol Biol Phys. 1988;14:1077-84, doi: 10.1016/0360-3016(88)90382-3. 58. Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of Merkel cell Epidemiology and treatment of Merkel cell carcinoma Duprat JP et al. carcinoma. Cancer. 1997;80:881-5, doi: 10.1002/(SICI)1097-0142(19970 901)80:5,881::AID-CNCR8.3.0.CO;2-O. 59. Tennvall J, Biorklund A, Johansson L, Akerman M. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients. Eur J Surg Oncol. 1989;15:1-9. 60. Gupta AS HS, Levine EA. Successful treatment of in-transit metastases from Merkel’s cell carcinoma with isolated hyperthermic limb perfusion. South Med J. 1998;91:4, doi: 10.1097/00007611-199810001-00002. 61. Olieman AF, Lienard D, Eggermont AM, Kroon BB, Lejeune FJ, Hoekstra HJ, et al. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg. 1999;134:303-7, doi: 10.1001/archsurg.134.3.303. 62. Lampreave JL, Benard F, Alavi A, Jimenez-Hoyuela J, Fraker D. PET evaluation of therapeutic limb perfusion in Merkel’s cell carcinoma. J Nucl Med. 1998;39:2087-90. 63. Helm KF, Billingsley EY, Zangwill BC, Schwartz RA. Localized limb cutaneous metastases. J Surg Oncol. 1998;67:261-4, doi: 10.1002/ (SICI)1096-9098(199804)67:4,261::AID-JSO10.3.0.CO;2-3. 64. Duprat JP, Domingues AL, Coelho EG, Leal RM, Nishinari K, Neves RI. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma. Eur J Surg Oncol. 2009;35: 568-72. 1823